ZL-1503

· Zai Lab (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZL-1503, covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis [Phase 1]

See pricing